Literature DB >> 6092811

Epidermal growth factor binding is altered in pancreatic acini from diabetic rats.

M Korc, L M Matrisian, R Nakamura, B E Magun.   

Abstract

The effects of streptozotocin-induced diabetes on 125I-labeled epidermal growth factor (EGF) binding were studied in rat pancreatic acini. 125I-EGF binding was one-half maximal at 20 min, and maximal at 90 min. Saturation data revealed a decreased binding capacity in diabetic acini when compared with normal acini. Insulin, in vivo, normalized the decreased binding capacity. 125I-EGF internalization was also decreased in diabetic rat acini. Further, the inhibitory effect of cholecystokinin-octapeptide (CCK8) on cell-associated 125I-EGF radioactivity was significantly greater in diabetic than in normal rat acini. These findings suggest that insulin deficiency may lead to defective regulation of the exocrine pancreas by EGF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092811     DOI: 10.1016/0024-3205(84)90562-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Release and binding of epidermal growth factor in the pancreas of rats.

Authors:  J Jaworek; S J Konturek; W Bielanski; J Bilski; M Hladij
Journal:  Int J Pancreatol       Date:  1992-02

2.  Alterations in EGF binding to acini during pancreatic regeneration in the rat.

Authors:  J S Brockenbrough; G C Weir; M Korc
Journal:  Int J Pancreatol       Date:  1988-12

Review 3.  Potential role of the epidermal growth factor receptor in human pancreatic cancer.

Authors:  M Korc
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

4.  Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.

Authors:  Ibrahim F Benter; Mariam H M Yousif; Sioned M Griffiths; Mustapha Benboubetra; Saghir Akhtar
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.